Eye of the beholder: Rare eye diseases in focus

The Eye of the Beholder.

Morton Ann GernsbAcher is the Vilas Research Professor and Sir Frederic C. Bartlett Professor of Psychology at the University of Wisconsin-Madison. She can be reached via email at [email protected]. I’m at the 15th percentile in height for U.S. females — a ranking I’ve held since birth. When I was growing up, there were certain occupations (e.g., flight attendant and firefig...

Processes Are in the Eye of the Beholder Processes Are in the Eye of the Beholder

The charter of SRC is to advance both the state of knowledge and the state of the art in computer systems. From our establishment in 1984, we h a v e performed basic and applied research to support Digital's business objectives. Our current w ork includes exploring distributed personal computing on multiple platforms, networking, programming technology, system modelling and management technique...

Obesity and Eye Diseases

Background: Obesity is a chronic metabolic disease that has become an epidemic today.  Objective: Although the effects of obesity on the body have been well studied, less is known about obesity and eye health. Methods The present article is a review study. The search was performed using keywords of obesity and eye diseases in PubMed, Scopus, Web of Science databases from 2000 to 2021.  Resul...

Corticotherapy in Eye Diseases and Its Complications

Corticosteroids are being rn;;ed in different ophthalmic disorder as anti-inflamatory agent.  A.C.T.H. stimulated the supra renal glands and causes an increase steroid concentration of the blood. Corticosteroids can be used as anti­inflamatory agent locally ar.d systemically.  The new corticom,teroids like prednison, dex­xametason and prednisolon are more effective ( 5 to 10 times) than the o...

Beauty in the Eye of the Beholder